Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer

British Journal of Cancer, Published online: 23 February 2024; doi:10.1038/s41416-024-02614-wCapivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer

Source: British Journal of Cancer - February 23, 2024 Category: Cancer & Oncology Authors: Cath Eberlein Stuart C. Williamson Lorna Hopcroft Susana Ros Jennifer I. Moss James Kerr Wytske M. van Weerden Elza C. de Bruin Shanade Dunn Brandon Willis Sarah J. Ross Claire Rooney Simon T. Barry Source Type: research